• Home
  • Business Core
  • R&D Pipeline
  • About Us
  • Tech Platform
    • Tech Platform
    • Tech Advantages
  • News Center
    • Company News
    • Academic Achievements
  • Contact
  • 中

News Center

Company News

  • Company News
  • Academic Achievements
    2026.02.10
    Good News! MOMED BIOTECH has been awarded the Top 30 Most Investment-Worthy Projects at the

    2026.01.13
    HEZE PHARMACEUTICAL Visits MOMED BIOTECH to Explore New Opportunities for Pharmaceutical Innovation and Collaboration

    2025.11.14
    Breaking News! MoMed Biotech Wins First Prize in the Growth Enterprise Category at the 2025

    2025.07.31
    T&K(Guangdong Taienkang Pharmaceutical Co., Ltd.‌) Visits MoMed Biotech, Jointly Exploring New Possibilities for Pharmaceutical Innovation Cooperation

    2025.06.19
    Breaking News | MoMed Biotech Discovers Novel Scaffold GCGR Biased Small-Molecule Inhibitor

<<<
    12345
>>>
  • Address: 4th Floor, Building 1, 600 Hongfeng Road, Linping District, Hangzhou City, Zhejiang Province

    Email: momedbusiness@momed.com.cn

    Phone: (0571) - 8610 3711


    • Corporate Official Account

    • Research Group Website

    • Business Core Business Core R&D Pipeline
    • About Us Company Profile Founding Team Development History
    • Tech Platform Research Platform for Mechanism of Target Proteins Artificial Intelligence Platform for Mining New Disease Pathways Target Protein Kinetics Database Artificial Intelligence Small Molecule Drug Design Platform AI-Based Macromolecular Drug Design Platform Multi-pipeline drug R&D platform Artificial Intelligence Platform for Predicting ADMET Properties of Drugs
    • News Center Company News Academic Achievements
    • Contact MoMed Contact Information Join MoMed
  • 2023 晨伫科技 浙ICP备2023014953号-1
  • 网站声明 | 隐私政策